What we're reading, January 24, 2017: senators introduce a bill to temporarily allow drug imports; PhRMA launches campaign to combat criticism of pharmaceutical industry; and the CDC canceled summit on climate change and health.
A new bill would permit drug imports to address shortages. According to STAT, 2 US senators introduced a bill that would temporarily allow prescription drugs to be imported into the United States when HHS decides there is a drug shortage. Only drugs from countries with the same safety and effectiveness standards as the United States would be eligible. The bipartisan legislation also seeks to speed approvals for treatments that have little competition through faster reviews and inspections. The FDA already has plans to speed up reviews for generic drugs in situations where only 1 treatment is current sold.
Drug lobby combats criticism with new campaign. President Donald J. Trump has strongly criticized the pharmaceutical industry—he said they are “getting away with murder”—and the Pharmaceutical Research and Manufacturers of American (PhRMA) has launched a new campaign to counter the negative image, reported The Hill. The campaign, called “Go Boldly,” highlights scientific advances made by pharmaceutical companies. PhRMA’s campaign will include TV, print, digital, and radio advertising.
CDC cancels summit on how climate change impacts health. Shortly before Trump’s inauguration, the CDC canceled the Climate and Health Summit with little fanfare. The Washington Post reported that speakers had been informed the February summit would not be held, but did not give any reason why. The agency is apparently considering rescheduling the event. The summit had been intended to discuss the evidence of risks to human health as a result of changing climate.
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Poor Well-Being Scores Linked to Early Treatment Stoppage in Multiple Myeloma
March 27th 2024Investigators used the Functional Assessment of Cancer Therapy-General General Physical Wellbeing Scale to collect data on patient-reported treatment-related adverse effects, to provide clinicians guidance on predicting risk of early treatment discontinuation among ECOG-ACRIN E1A11 trial participants.
Read More